Lead Pb 212 pentixather
Term · Oncology and biomedicine · MLC-T-ONC-014729
A radioconjugate composed of pentixather, a chemokine receptor C-X-C chemokine receptor type 4 (CXCR4)-targeting ligand, conjugated to the alpha-emitting radioisotope lead Pb 212, with potential antineoplastic activity. Upon administration, lead Pb 212 pentixather targets and binds to CXCR4-expressing cancer cells. This allows for the specific delivery of a cytotoxic dose of alpha radiation to CXCR4-expressing cancer cells. CXCR4, a marker of poorly differentiated cells, is overexpressed on various cancer cells, and plays a key role in tumor growth, progression, invasiveness and metastasis.
| Identifier | MLC-T-ONC-014729 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 212Pb-pentixather; lead 212-labeled pentixather; 212-lead pentixather; lead Pb 212-pentixather |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014729",
"term": "Lead Pb 212 pentixather",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate composed of pentixather, a chemokine receptor C-X-C chemokine receptor type 4 (CXCR4)-targeting ligand, conjugated to the alpha-emitting radioisotope lead Pb 212, with potential antineoplastic activity. Upon administration, lead Pb 212 pentixather targets and binds to CXCR4-expressing cancer cells. This allows for the specific delivery of a cytotoxic dose of alpha radiation to CXCR4-expressing cancer cells. CXCR4, a marker of poorly differentiated cells, is overexpressed on various cancer cells, and plays a key role in tumor growth, progression, invasiveness and metastasis.",
"synonyms": [
"212Pb-pentixather",
"lead 212-labeled pentixather",
"212-lead pentixather",
"lead Pb 212-pentixather"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lead-pb-212-pentixather/"
}
Record 9,981 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.